Filippo Gustavo Dall'Olio (Filippo G Dall'Olio)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Renal Cell Carcinoma

Small Cell Lung Cancer

Top Venues

Future oncology (London, England)

Therapeutic advances in medical oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Filippo Gustavo Dall'Olio, Claudia Parisi, Laura Marcolin, Stefano Brocchi, Caroline Caramella, Nicole Conci, Giulia Carpani, Francesco Gelsomino, Stefano Ardizzoni, Paola Valeria Marchese, Alexandro Paccapelo, Giada Grilli, Rita Golfieri, Benjamin Besse, Andrea Ardizzoni
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC. Therapeutic advances in medical oncology 14 (2022)
Fabrice Barlesi, Pascale Tomasini, Maryam Karimi, Stefan Michiels, Judith Raimbourg, Catherine Daniel, Henri Janicot, Anne Madroszyk, Clarisse Audigier-Valette, Elisabeth Quoix, Julien Mazieres, Denis Moro-Sibilot, Eric Dansin, Olivier Molinier, Hugues Morel, Eric Pichon, Alexis B Cortot, Josiane Otto, François Chomy, Pierre-Jean Souquet, Nicolas Cloarec, Etienne Giroux-Leprieur, Ivan Bièche, Ludovic Lacroix, Sandrine Boyault, Valerie Attignon, Isabelle Soubeyran, Alain Morel, Alicia Tran-Dien, Alexandra Jacquet, Filippo Gustavo Dall'Olio, Marta Jimenez, Jean-Charles Soria, Benjamin Besse
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Alessandro Rizzo, Veronica Mollica, Filippo Gustavo Dall'Olio, Angela Dalia Ricci, Ilaria Maggio, Andrea Marchetti, Matteo Rosellini, Matteo Santoni, Andrea Ardizzoni, Francesco Massari
Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic review. Future oncology (London, England) 17 (20) (2021)
Veronica Mollica, Stefano Brocchi, Filippo Gustavo Dall'Olio, Laura Marcolin, Alexandro Paccapelo, Matteo Santoni, Alessandro Rizzo, Rodolfo Montironi, Rita Golfieri, Francesco Massari, Andrea Ardizzoni
Tumor Growth Rate Decline despite Progressive Disease May Predict Improved Nivolumab Treatment Outcome in mRCC: When RECIST Is Not Enough. Cancers 13 (14) (2021)
Filippo Gustavo Dall'Olio, Alessandro Rizzo, Veronica Mollica, Maria Massucci, Ilaria Maggio, Francesco Massari
Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysis. Immunotherapy 13 (3) (2020)
Tommaso Cavalleri, Andrea Sartore-Bianchi, Gianluca Basso, Giuseppe Celesti, Fabio Grizzi, Paola Bossi, Luana Greco, Calogero Pitrone, Emanuele Valtorta, Gianluca Mauri, Mauro Truini, Filippo Gustavo Dall'Olio, Giovanni Brandi, Luigi Ricciardiello, Valter Torri, Lorenza Rimassa, Salvatore Siena, Alberto Mantovani, Alberto Malesci, Luigi Laghi, null null
Combined Low Densities of FoxP3+ and CD3+ Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression. Cancer immunology research 7 (5) (2019)